About Jason Werner
Jason Werner is a president and director at SightStream Biotherapeutics.
Jason Werner first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Jason Werner in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jason Werner works with at each company, as listed on that company's latest Form D.
SightStream Biotherapeutics, Inc. · Form D, Oct 16, 2025